Alarming eosinophils to combat tumors
- 18 February 2019
- journal article
- editorial
- Published by Springer Nature in Nature Immunology
- Vol. 20 (3) , 250-252
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhighneutrophilsScience, 2017
- Eosinophils: The unsung heroes in cancer?OncoImmunology, 2017
- Emerging Roles for Eosinophils in the Tumor MicroenvironmentTrends in Cancer, 2016
- Modulation of Hematopoietic Chemokine Effects In Vitro and In Vivo by DPP-4/CD26Stem Cells and Development, 2016
- Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapyNature Immunology, 2015
- Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell typesBlood, 2013
- Identification of Innate IL-5–Producing Cells and Their Role in Lung Eosinophil Regulation and Antitumor ImmunityThe Journal of Immunology, 2012
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008
- Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophilsBlood, 2007
- Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host responseJournal of Leukocyte Biology, 2006